Immune dysfunction in Australian Aborigines

Asian Pacific Journal of Allergy and Immunology

Volumn 23, Issue 4, 2005, Pages 235-244

  Roberts Thomson, Peter J ^a   Roberts Thomson, R A ^b   Nikoloutsopoulos, T ^a   Gillis, D ^c  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA B27 ANTIGEN;

ABORIGINE; ALLERGIC DISEASE; ALLERGIC GLOMERULONEPHRITIS; ANKYLOSING SPONDYLITIS; ARTHROPATHY; ARTICLE; ATOPY; AUSTRALIA; AUTOIMMUNE DISEASE; BILIARY CIRRHOSIS; CELIAC DISEASE; CONNECTIVE TISSUE DISEASE; GENE LOCUS; HIGH RISK POPULATION; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOPATHOLOGY; INFECTION; INFECTION SENSITIVITY; INNATE IMMUNITY; LIFESTYLE; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; PATHOGENESIS; PERNICIOUS ANEMIA; PHENOTYPE; PREVALENCE; PSORIASIS; RACE DIFFERENCE; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS; SOCIAL ISOLATION; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS; VITILIGO;

AUSTRALIA; HUMANS; IMMUNE SYSTEM DISEASES; OCEANIC ANCESTRY GROUP; PREVALENCE;

EID: 33645296868     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Gao X, Serjeantson SW, Diversity in HLA-DR4-related DR, DQ haplotypes in Australia, Oceania and China. Human Immunol 199 1; 32: 269-76.
2. Lester S, Cassidy S, Humphreys I, Bennett G, Hurley CK, Boettcher B, et al. Evolution in HLA-DRBl and major histocompatibility complex class II haplotypes of Australian Aborigines. Definition of a new DRB1 allele and distribution of DRB1 gene frequencies. Hum Inummol 1995; 42: 154-60.
3. Thomson N. Aboriginal health-current status. Aust NZ J Med 1984; 14: 705-18.
4. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Short analytical review. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-43. Article No. II974412.
5. Basedow H. The Australian Aboriginals. Adelaide, Preesce. 1925.
6. Caseley-Smith J.R. The haematology of the Central Australian Aborigine. II. White cell and differential counts, eosinophil counts and Casoni tests. Aust J Exp Biol Med Sci 1959; 37: 481-7.
7. Christiansen FT, Zhang WJ, Griffiths M, Mallal SA, Dawkins RL. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol 1991; 18: 1350-8.
8. Turner MW, Dinan L, Heatley S, Jack KL, Boettcher B, Lester S, McCluskey J, Roberton I. Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet 2000; 9: 1481-6.
9. Immunology Unit. Menzies School of Health Research Annual Report 1990-91.
10. Caseley-Smith JR. The haematology of the Central Australian Aborigine. III. Lymphocyte and haemograms, with European controls. Aust J Exp Biol Med Sci 1959; 37: 517-21.
11. Gardner I, Webb D, Chambers L, Wie J, Geddes T, Milns N. Studies of cellular immunity in Aborigines. Menzies School Health Research. Annual Report 88/89; 121-2.
12. Gillen CM, Towers RJ, McMillan DJ, Delvecchio A, Sriprakash KS, Currie B, Kreikemeye Chhatwal GS, Walker MJ. Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor. Microbiology 2002; 148: 169-78.
13. Bower C, Condon R, Payne J, Burton P, Watson C, Wild B. Measuring the impact of conjugate vaccines on invasive Haemophilus influenzae type b infection in Western Australia. Aust N Z J Public Health 1998; 22: 67-72.
14. Flannery G, White N. Immunological parameters in northeast Arnhem Land Aborigines: consequences of changing settlement patterns and lifestyles. Urban Ecology and Health in the Third World. In: LM Schell, MT Smith, A Bilsborough, eds. Cambridge University Press, Cambridge, 1993.
15. Stuart J. The development of serum immunoglobulins G, A and M in Australian Aboriginal infants. Med J Aust 1978; 1 Suppl 1: 4-5.
16. Rawlinson ED, Basten A, Hargrave JC. Clinical significance of changes in serum proteins, immunoglobulins, and autoan-tibodies in leprosy. Int J Lepr Other Myobact Dis 1987; 55: 277-85.
17. Setjeantson SW. HLA and Disease in Oceania. Human Generics Group, John Curtin School of Medical Research, Canberra, Australia. ACT 2601, Australia.
18. Jose DG, Shelton M, Tauro GP, Belbin R, Hosking CS. Deficiency of immunological and phagocytic function in Aboriginal children with protein-calorie malnutrition. Med J Aust 1975; 2: 699-705.
19. Guthrie JA, Dore GJ, McDonald AM, Kaldor JM. HIV and AIDS in Aboriginal and Torres Strait Islander Australians: 1992-1998. The National HIV Surveillance Committee. Med J Aust 2000; 172: 266-9.
20. Brennan RE, Patel MS. Acute rheumatic fever and rheumatic heart disease in a rural central Australian Aboriginal community. Med J Aust 1990; 153: 335, 338-9.
21. Hartas J, Goodfellow AM, Currie BJ, Sriprakash KS. Characterisation of group A streptococcal isolates from Tropical Australia with high prevalences of rheumatic fever: probing for signature sequences to identify members of the family of serotype 5. Microb Pathog 1995; 18: 345-54.
22. Carapetis JR, Currie BJ. Editorials - preventing rheumatic heart disease in Australia. Med J Aust 1998; 168: 425-9.
23. Patten BR. Rheumatic fever in the West Kimberly. Med J Aust 1981; 1 (suppl 2): 11-5.
24. Basedow H. Diseases of the Australian Aborigines. J Trop Med Hygiene 1932; 35: 209-32.
25. Acute post-streptococcal glomerulonephritis. Menzies School of Health Research 1996-7 Annual Report.
26. Roberts-Thomson PJ. Does rheumatoid arthritis exist in the indigenous Australian Aboriginal population? (Letter) Med J Aust 1995; 163: 444-5.
27. Cleland JB. Disease amongst the Australian Aborigines Part IV. Diseases of the joints, bones and muscles. J Trop Med Hygiene 1928; 31: 202-5.
28. Douglas WA. Does rheumatoid arthritis exist in the indigenous Australian Aboriginal population? (Letter). Med J Aust 1996; 164: 191-2.
29. Roberts-Thomson PJ, Hedger S, Bossingham D. Rheumatoid arthritis and Australian Aborigines. Med J Aust 1998; 168: 92-3.
30. Cregersen PK, Silver J. Winchester RJ. The shared epitope hypothesis. Arthritis Rheum 1987; 30: 1205-313.
31. Pile KD, Richens JE, Laurent RM, Bhatia K, Prasad ML, Lupiwa T, et al. Arthritis in the highlands of Papua New Guinea. Ann Rheum Dis 1993; 52: 49-52.
32. Silman AJ, Ollier W, Holligan S, Birrell F, Adebajo A, Asuzu MC, et al. Absence of rheumatoid arthritis in a rural Nigerian population. J Rheumatol 1993; 20: 618-22.
33. Chou CT, Schumacher HR. Human Leucocyte antigens (classes I and 11) in central Taiwan Aborigines: can these explain the observed differences in rheumatic disease patterns compared with Han Chinese? Rheumatology 2000; 39: 1297-9.
34. Bloor G, Rigby RJ, Richmond JM, Zilko PJ, Dawkins RL. Systemic lupus erythematosus in Australian Aborigines. (Abstract). Aust NZ J Med 1982; 12: 553.
35. Grennan DM, Bossingham D. Systemic lupus erythematosus (SLE) different prevalences in different populations of Australian Aboriginals. Aust NZ J Med 1995; 25: 182-3.
36. Ansley NM, Dunckley H, Bastian I, Currie BJ. Systemic lupus erythematosus in Australian Aborigine: high prevalence, morbility and mortality. Aust NZ J Med 1993; 23: 646-51.
37. Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus 2001; 10: 439-44.
38. Green A. Discoid erythematosus in Australian Aborigines. Australas J Dermatol 1995; 36: 175-7.
39. Ranford P, Serjeantson SW, Hay J, Dunckley H. A high frequency of inherited deficiency of complement component C4 in Darwin Aboriginals. Aust NZ J Med 1987; 17: 420-3.
40. Anstey NM, Bastian I, Dunckley H, Currie BJ. Systemic lupus erythernatosus (SLE): different prevalences in different populations of Australian Aborigines. Aust NZ J Med 1995; 25: 736-7.
41. Zurauskas J, Beroukas D, Waler JG, Smith MD, Ahern MJ, Roberts-Thomson PJ. Scleroderma in Australian Aborigines. Int Med J 2005; 35: 60-2.
42. McLeod JG, Hammond SR, Hallpike JF. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. Med J Aust 1994; 160: 117-22.
43. Barbato MP, Agar NS, Kirk RL. Thyroid autoantibodies in Aborigines. Med J Aust 1980; 1: 543-5.
44. Webb S. Paleopathology of Aboriginal Australians. Melbourne: Cambridge Univeristy Press 1995; pp. 167-76.
45. Arnett FC, Charkraborty R. Ankylosing spondylitis: the dissection of a complex genetic disease. Arthritis Rheum 1997; 40: 1746-8.
46. Cleland LG, Hay JAR, Milazzo SC. Absence of HLA-1327 and of ankylosing spondylitis in central Australian Aboriginals. Scand J Rheumatol 1975; 4 (suppl 8): 30-5.
47. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995; 7: 263-9.
48. Green AC. Australian Aborigines and psoriasis. Australas J Dermatol 1984; 25: 18-24.
49. Lester S, Cavill D, Roberts-Thomson PJ, Rischmueller, Bardy P, McCluskey J, Gordon TP. The development of Anti-Ro autoantibodies is controlled by ethnically distinct immunogenetic determinants within the MHC. Arthritis & Rheumatism 1999; 9 (Supp): 112.
50. Roberts-Thomson PJ, Nikoloutsopoulos, Cox S, Walker JG, Gordon TP. Antinuclear antibody testing in a regional immunopathology laboratory. Immunol Cell Biol 2003; 81: 409-12.
51. Veale AJ, Peat JK, Tovey ER, Salome CM, Thompson JE, Woolcock AJ. Asthma and atopy in four rural Australian Aboriginal communities. Med J Aust. 1996; 165: 192-6.
52. Downs SH, Marks GB, Belosouva EG, Peat JK. Asthma and hayfever in Aboriginal and non-Aboriginal children living in non-remote rural towns. Med J Aust 2001; 175:10-3.
53. Vedeijden MW, Ton A, James AL, Wood M, Musk AW. Respiratory Medicine and lung function in two Aboriginal communities in Western Australia.
54. Valery PC, Chang AB, Shibasaki S, Gibson O, Purdie DM, Shannon C, Masters IB. High prevalence of asthma in five remote indigenous communities in Australia. Eur Respir J 2001; 17: 1089-96.
55. Moffatt MF, Faux JA, Lester S, Pare P, McCluskey J, Spargo R, James A, Musk AW, Cookson WO. Atopy, respiratory function and HLA-DR in Aboriginal Australians. Hum Mol Genet 2003; 12: 625-30.
56. Palmer LJ, Pare PD, Faux JA, Moffatt MF, Daniels SE, Le-Souef PN, Bremner PR, Mockfo E, Gracey M, Spargo R, Musk AW, Cookson WO. Fc epsilon R1-beta polymorphism and total serum IgE levels in endemically parasitized Australian Aborigines. Am J Hum Genet 1997; 611: 182-8.
57. Condon JR, Armstrong BK, Barnes A, Cunningham J. Cancer in indigenous Australians: a review. Cancer Causes Control 2003; 14: 109-21.
58. Bastian I, Hinuma Y, Doherty RR. HTLV-I among Northern Territory Aborigines. Med J Aust 1993; 159: 12-6.
59. Doherty RR. HTLV-I in Australia and Oceania: long-term resident or recent immigrant? Med J Aust 1996; 164: 84-6.
60. Kirkland MA, Frasca J, Bastian I. Adult T-cell leukaemia lymphoma in an Aborigine. Aust NZ J Med 1991; 21: 739-41.
61. Nerurkar VR, Song KJ, Bastian IB, Garin B, Franchini G, Yanagihara R. Genotyping of human T cell lymphotropic virus type I using Australo-Melanesian topotype-specific oligonucleotide primer-based polymerase chain reaction: insights into viral evolution and dissemination. J Infect Dis 1994; 170: 1353-60.
62. Healey T, Olver I, Selva-Nayagam S. Immunoproliferative small intestinal disease, two cases in the Northern Territory. Intern Med J 2002; 32: 47-9.
63. Bateson EM, Rode J. The pitted Aboriginal skull. Radiological appearances and resemblance to myelomatosis. Australas Radiol 1977; 21: 112-5.
64. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Eng J Med 2002; 347: 911-20.